Literature DB >> 19185555

A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.

Y-H Yen1, C-S Changchien, J-H Wang, K-M Kee, C-H Hung, T-H Hu, C-M Lee, C-Y Lin, C-C Wang, T-Y Chen, Y-J Huang, S-N Lu.   

Abstract

BACKGROUND: Combinations of Child-Pugh classification and Liver Cancer Study Group of Japan/Tumor-Node-Metastasis (LCSGJ/TNM) have been reported as Japan Integrated Staging (JIS). We previously modified the 6th AJCC/TNM to serve as a better staging system than the 5th and 6th AJCC/TNM. AIMS: To develop a modified TNM-based JIS to predict the survival of hepatocellular carcinoma (HCC) patients more accurately.
METHODS: 3764 HCC patients were enrolled from 1986 to 2002 (2882 patients from 1986 to 2000 and 882 patients from 2001 to 2002). We compared the performance of original JIS, modified TNM-based JIS, modified TNM-based JIS combined alpha-fetoprotein (AFP), BCLC, and CLIP. Lower Akaike information criteria (AIC) values indicated better discriminatory abilities.
RESULTS: AIC value was lowest in CLIP during all periods. However, during 2001-2002, when early-stage HCC patients were predominant, AIC value was lowest when modified TNM-based JIS combined AFP was used.
CONCLUSION: The CLIP system provided the best prognostic stratification in the present cohort of HCC patients who were mainly at late stages. However, early detection of HCCs has become more common in Taiwan in recent years, which has led to the predominance of early-stage HCC patients. Therefore, modified TNM-based JIS combined AFP may now be the most applicable system in recent years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185555     DOI: 10.1016/j.dld.2008.11.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  13 in total

1.  Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: a single European center experience of 426 patients.

Authors:  Roberto Santambrogio; Matteo Barabino; Savino Bruno; Mara Costa; Andrea Pisani Ceretti; Maria Rachele Angiolini; Massimo Zuin; Franca Meloni; Enrico Opocher
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

2.  Proposal of new classification for postoperative patients with hepatocellular carcinoma based on tumor growth characteristics.

Authors:  Cui-Hong Zhu; Xiao-Hui Liu; Rui Cao; Xiong-Zhi Wu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  HCC in older patients.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

4.  Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy.

Authors:  Jianguo Zhou; Tao Yan; Xinyu Bi; Hong Zhao; Zhen Huang; Yefan Zhang; Yuan Li; Li Feng; Jing Wang; Jianqiang Cai
Journal:  Tumour Biol       Date:  2013-01-16

5.  Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center.

Authors:  Kwong-Ming Kee; Jing-Houng Wang; Chih-Yun Lin; Chih-Chi Wang; Yu-Fan Cheng; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2013-05-24       Impact factor: 3.199

6.  Comparison of staging systems of hepatocellular carcinoma.

Authors:  Yongyut Sirivatanauksorn; Chutwichai Tovikkai
Journal:  HPB Surg       Date:  2011-06-27

7.  Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.

Authors:  Asmaa Ibrahim Gomaa; Mohamed Saad Hashim; Imam Waked
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

8.  Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.

Authors:  Jian-Jun Zhao; Tao Yan; Hong Zhao; Jian-Guo Zhou; Zhen Huang; Ye-Fan Zhang; Yuan Li; Zhi-Yu Li; Xin-Yu Bi; Jian-Qiang Cai
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

9.  Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma.

Authors:  Guang-Bing Li; Xue-Li Zhang; Li Yuan; Qi-Qi Jiao; De-Jie Liu; Jun Liu
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma.

Authors:  Zhen You; Li-Ping Chen; Hui Ye
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.